CN101018563A - 衍生自cap18的抗菌肽 - Google Patents

衍生自cap18的抗菌肽 Download PDF

Info

Publication number
CN101018563A
CN101018563A CNA2005800255122A CN200580025512A CN101018563A CN 101018563 A CN101018563 A CN 101018563A CN A2005800255122 A CNA2005800255122 A CN A2005800255122A CN 200580025512 A CN200580025512 A CN 200580025512A CN 101018563 A CN101018563 A CN 101018563A
Authority
CN
China
Prior art keywords
use according
peptide
infection
chemical compound
bacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2005800255122A
Other languages
English (en)
Chinese (zh)
Inventor
约翰内斯·雅格布斯·格罗特
扬·沃特·德费豪特
彼得·西科·西姆斯特拉
马尔特耶·约翰娜·内尔
马赛尔·扬·翁卡
吉多·文森特·布隆伯格
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leids Universitair Medisch Centrum LUMC
OctoPlus Technologies BV
Original Assignee
Leids Universitair Medisch Centrum LUMC
OctoPlus Technologies BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leids Universitair Medisch Centrum LUMC, OctoPlus Technologies BV filed Critical Leids Universitair Medisch Centrum LUMC
Publication of CN101018563A publication Critical patent/CN101018563A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
CNA2005800255122A 2004-07-28 2005-07-26 衍生自cap18的抗菌肽 Pending CN101018563A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04077175A EP1621205A1 (en) 2004-07-28 2004-07-28 Antimicrobial peptides derived from CAP18
EP04077175.0 2004-07-28

Publications (1)

Publication Number Publication Date
CN101018563A true CN101018563A (zh) 2007-08-15

Family

ID=34928414

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2005800255122A Pending CN101018563A (zh) 2004-07-28 2005-07-26 衍生自cap18的抗菌肽

Country Status (11)

Country Link
US (2) US7803756B2 (https=)
EP (3) EP1621205A1 (https=)
JP (1) JP2008508265A (https=)
KR (1) KR20070050941A (https=)
CN (1) CN101018563A (https=)
AU (1) AU2005267651B2 (https=)
BR (1) BRPI0513856A (https=)
CA (1) CA2574959A1 (https=)
NZ (1) NZ553175A (https=)
RU (1) RU2392962C2 (https=)
WO (1) WO2006011792A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105555290A (zh) * 2013-05-10 2016-05-04 莱顿大学学术医院以Lumc的名义运作 抗微生物肽

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1621205A1 (en) * 2004-07-28 2006-02-01 OctoPlus Technologies B.V. Antimicrobial peptides derived from CAP18
JP5762683B2 (ja) 2006-12-01 2015-08-12 ラクレード，インコーポレーテッド 耳内のバイオフィルムを溶解するための加水分解酵素及び酸化酵素の使用
EP2175865A4 (en) 2007-07-25 2012-01-11 Biolex Therapeutics Inc INTERFERON DRUG PRODUCTS WITH CONTROLLED RELEASE AND TREATMENT OF HCV INFECTIONS THEREWITH
US20110039763A1 (en) 2009-01-06 2011-02-17 C3 Jian, Inc. Targeted antimicrobial moieties
US20130079382A1 (en) 2009-10-12 2013-03-28 Larry J. Smith Methods and Compositions for Modulating Gene Expression Using Oligonucleotide Based Drugs Administered in vivo or in vitro
RU2434880C1 (ru) * 2010-07-21 2011-11-27 Общество С Ограниченной Ответственностью "Биохарт" Полипептид, имеющий антибактериальную активность и пригодный для получения лекарственных средств для лечения бактериальных инфекций человека
BR112014027818B1 (pt) * 2012-05-09 2023-03-28 Contrafect Corporation Usos de composições compreendendo polipeptídeo de lisina para prevenção, ruptura ou tratamento de um biofilme bacteriano
US9387189B2 (en) 2013-05-22 2016-07-12 Professional Compounding Centers Of America (Pcca) Antibiotic composition comprising a chemotactic agent and a nutrient dispersion
WO2015075406A1 (en) * 2013-11-19 2015-05-28 Lipopeptide Ab New treatment of chronic ulcers
PL3087092T3 (pl) 2013-12-12 2018-12-31 Academisch Ziekenhuis Leiden H.O.D.N. Lumc Peptyd przeciwdrobnoustrojowy i jego zastosowania
WO2015164289A1 (en) * 2014-04-21 2015-10-29 Cidara Therapeutics, Inc. Compositions and methods for the treatment of fungal infections
US20250034218A1 (en) * 2021-09-21 2025-01-30 Biomedit, Llc Antimicrobial peptides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4037525B2 (ja) * 1998-03-25 2008-01-23 生化学工業株式会社 新規抗菌性ペプチド
ATE435870T1 (de) * 2003-01-28 2009-07-15 Academisch Ziekenhuis Leiden Aus ll-37 abgeleiteten peptidinhibitoren von toxinen
WO2005040192A2 (en) * 2003-10-21 2005-05-06 The Regents Of The University Of California Human cathelicidin antimicrobial peptides
EP1621205A1 (en) * 2004-07-28 2006-02-01 OctoPlus Technologies B.V. Antimicrobial peptides derived from CAP18

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105555290A (zh) * 2013-05-10 2016-05-04 莱顿大学学术医院以Lumc的名义运作 抗微生物肽
CN105555290B (zh) * 2013-05-10 2021-11-09 莱顿大学学术医院以Lumc的名义运作 抗微生物肽

Also Published As

Publication number Publication date
WO2006011792A3 (en) 2006-09-14
KR20070050941A (ko) 2007-05-16
BRPI0513856A (pt) 2008-05-20
CA2574959A1 (en) 2006-02-02
EP1621205A1 (en) 2006-02-01
WO2006011792A2 (en) 2006-02-02
AU2005267651B2 (en) 2010-05-27
JP2008508265A (ja) 2008-03-21
EP1784206A2 (en) 2007-05-16
RU2392962C2 (ru) 2010-06-27
EP2221061A1 (en) 2010-08-25
US20110053835A1 (en) 2011-03-03
US7803756B2 (en) 2010-09-28
NZ553175A (en) 2009-10-30
AU2005267651A1 (en) 2006-02-02
US20080249022A1 (en) 2008-10-09
RU2007107390A (ru) 2008-09-10

Similar Documents

Publication Publication Date Title
US9872885B2 (en) Antimicrobial and anti-inflammatory peptides
KR101922409B1 (ko) 화합물들 및 그 용도
ES2264198T3 (es) Composiciones y metodos para tratar infecciones utilizando peptidos cationicos a solas o en combinacion con antibioticos.
US20110053835A1 (en) Antimicrobial peptides derived from cap18
JP2002541066A (ja) 抗微生物薬／エンドトキシンを中和するポリペプチド
US7807617B2 (en) Peptide inhibitors of toxins derived from LL-37
JP5140579B2 (ja) 病原菌に対する生体防御を増強するヒアルロン酸結合性ペプチド
US7824691B2 (en) Use of RIP in treating staphylococcus aureus infections
US20210324359A1 (en) Use of gram-negative lysin-antimicrobial peptide (amp) polypeptide constructs in treating endocarditis
CN115960163A (zh) 抗菌肽、包含抗菌肽的药物组合物及其应用
HK1102693A (en) Antimicrobial peptides derived from cap18
HK1088613B (en) Peptide inhibitors of toxins derived from ll-37

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1102693

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20070815

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1102693

Country of ref document: HK